| CAT No: | CL-BRI-47 |
| CAS No: | 2910813-45-3 |
| Mol.F: | C22H20N10O2S |
| Mol.Wt.: | 488.5 |
| Rel. Cas No: | |
| Chemical Name: | 2-(3-(4-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Pyrrolopyrimidine Baricitinib is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pyrrolopyrimidine Baricitinib is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(3-(4-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrileCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Baricitinib Molecular Formula: C22H20N10O2S
Molecular Weight: 488.5
Storage: Store in a cool, dry place.
| Product Name: | Pyrrolopyrimidine Baricitinib |
| CAS No: | 2910813-45-3 |
| Mol.F.: | C22H20N10O2S |
| Mol.Wt.: | 488.5 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: